Fondazione Irccs Istituto Nazionale Dei Tumori, Milano
Clinical trials sponsored by Fondazione Irccs Istituto Nazionale Dei Tumori, Milano, explained in plain language.
-
Breath test could spot breast cancer without needles or scans
Diagnosis OngoingThis study is testing whether a simple breath test can tell if a woman has breast cancer. Researchers are collecting breath samples from 1000 women — half with breast cancer and half without — and analyzing them with a mass spectrometer. The goal is to see if the chemical signatu…
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Diagnosis
Last updated Jun 27, 2026 12:34 UTC
-
Triple-Pronged attack on lung cancer: aspirin, smoking cessation, and lifestyle changes tested in new trial
Prevention OngoingThis study tests whether a combination of low-dose aspirin, a smoking cessation drug called cytisine, and guidance on diet and exercise can reduce chronic inflammation and lower lung cancer risk in heavy smokers aged 55 to 75. The 2000 participants will also receive annual low-do…
Phase: PHASE2 • Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
AI + blood test could spot lung cancer earlier in smokers
Knowledge-focused OngoingThis study tests whether combining artificial intelligence with blood biomarkers and CT scan features can better predict lung cancer risk in heavy smokers. Researchers will analyze data from 650 participants to develop a risk model that improves screening accuracy and reduces unn…
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
New national registry aims to improve care for rare genetic polyposis syndromes
Knowledge-focused OngoingThis study is a national registry collecting data from 1500 people with familial adenomatous polyposis (FAP) and related conditions across 28 Italian centers. It aims to better understand how these diseases progress, how they are currently managed, and what factors influence outc…
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
New study aims to crack the code of kidney cancer treatment response
Knowledge-focused OngoingThis study is looking for clues in blood, tumor tissue, and CT scans to help doctors choose the best first treatment for people with metastatic clear cell kidney cancer. Researchers will analyze genetic material and imaging features from 100 patients to see if they can predict wh…
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:46 UTC